started · updated
IPO de Coimbra receives European oncology distinction
The Portuguese Institute of Oncology of Coimbra Francisco Gentil (IPO de Coimbra) has been recognized by the European Society for Medical Oncology (ESMO) as an ‘ESMO Designated Centre of Integrated Oncology and Palliative Care’. This distinction is valid for the period from 2027 to 2029.
The accreditation highlights the institution's ability to integrate oncological treatments with palliative care, focusing on a person-centered approach that addresses the physical, emotional, and social needs of patients and their families. The ESMO program aims to promote continuity of care, professional training, and research through an international network of over 260 accredited centers across 58 countries.
Entities
Coimbra · European Society for Medical Oncology · Instituto Português de Oncologia de Coimbra Francisco Gentil